| SCHEDULE OF LOSS PER SHARE, BASIC AND DILUTED |
A
reconciliation of the numerators and denominators of the basic and diluted loss per share calculations for the three and six months ended
June 30, 2026 and 2025 was as follows:
SCHEDULE OF LOSS PER SHARE, BASIC AND DILUTED
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three
Months Ended June
30, | | |
Six
Months Ended June
30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Loss
per share attributable to common shareholders (“EPS”): | |
| | | |
| | | |
| | | |
| | |
| Basic | |
$ | (0.66 | ) | |
$ | (0.23 | ) | |
$ | (1.84 | ) | |
$ | (0.82 | ) |
| Diluted | |
$ | (0.66 | ) | |
$ | (0.23 | ) | |
$ | (1.84 | ) | |
$ | (0.82 | ) |
| EPS
numerator - basic and diluted: | |
| | | |
| | | |
| | | |
| | |
| Net
loss attributable to common shareholders | |
$ | (2,451 | ) | |
$ | (688 | ) | |
$ | (6,836 | ) | |
$ | (2,444 | ) |
| EPS
denominator (in thousands): | |
| | | |
| | | |
| | | |
| | |
| Weighted
average common stock outstanding - basic | |
| 3,704 | | |
| 2,995 | | |
| 3,724 | | |
| 2,990 | |
| Common
stock equivalents: restricted stock units and restricted shares of common stock (a) | |
| - | | |
| - | | |
| - | | |
| - | |
| Weighted
average number of common stock outstanding - diluted | |
| 3,704 | | |
| 2,995 | | |
| 3,724 | | |
| 2,990 | |
| (a) |
The
diluted weighted average number of shares of common stock outstanding did not differ from the basic weighted average number of shares
of common stock outstanding because the effects of any potential common stock equivalents (see Note 6 to the Condensed Consolidated
Financial Statements for further details on unvested restricted stock units) were anti-dilutive and therefore not included in the
calculation of the denominator of dilutive earnings per share. |
|
A
reconciliation of the numerators and denominators of the basic and diluted loss per share calculations were as follows:
SCHEDULE OF LOSS PER SHARE, BASIC AND DILUTED
| | |
| | | |
| | |
| | |
For
The Year Ended December 31, | |
| | |
2025 | | |
2024 | |
| Loss
per share attributable to common shareholders (“EPS”): | |
| | | |
| | |
| Basic | |
$ | (2.08 | ) | |
$ | (1.59 | ) |
| Diluted | |
$ | (2.08 | ) | |
$ | (1.59 | ) |
| EPS
numerator - basic and diluted: | |
| | | |
| | |
| Net
loss attributable to common shareholders | |
$ | (6,657 | ) | |
$ | (4,770 | ) |
| EPS
denominator (in thousands): | |
| | | |
| | |
| Weighted
average common stock outstanding - basic | |
| 3,198 | | |
| 3,000 | |
| Common
stock equivalents: stock options and restricted stock units | |
(a) | - | | |
(a) | - | |
| Weighted
average number of common stock outstanding - diluted | |
| 3,198 | | |
| 3,000 | |
| (a) | The
diluted weighted average number of shares of common stock outstanding did not differ from
the basic weighted average number of shares of common stock outstanding because the effects
of any potential common stock equivalents (see Note 7 to the Consolidated Financial Statements
for further details on unvested restricted stock units) were anti-dilutive and therefore
not included in the calculation of the denominator of dilutive earnings per share. |
|